Cenna Biosciences

United States
San Diego, California, United States

Company profile

Cenna Biosciences company profile

Cenna Biosciences develops disease modifying drugs for Alzheimer's disease using a proprietary novel mechanism.

Business identity

Contact email
[email protected]
Phone number
858-456-0820
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2006-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $2.7M / 2024-09-23
Investors
2
Lead investors
2
Founders
2
Articles
1

Founders and investors

Founders

Jonathan SingerNazneen Dewji

Lead investors

National Institute on AgingNational Institutes of Health

Investors

National Institute on AgingNational Institutes of Health